Overview

PET Detection of CCR2 in Human Atherosclerosis

Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
Phase:
Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid